Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis

NCT04453111 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

BIOLOGICAL: Placenta-derived MMSCs
BIOLOGICAL: Bone marrow-derived MMSCs
DRUG: Hyalgan 20 mg in 2 ML Prefilled Syringe

Sponsor

Institute of Cell Therapy

Collaborators

[object Object]
[object Object]